Teladoc Health, Inc. (BMV:TDOC)
Mexico · Delayed Price · Currency is MXN | Market Cap | 20.58B -12.2% |
| Revenue (ttm) | 45.33B -1.5% |
| Net Income | -3.09B |
| EPS | -17.39 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 1,206 |
| Open | 111.00 |
| Previous Close | 111.00 |
| Day's Range | 111.00 - 111.00 |
| 52-Week Range | 78.00 - 176.00 |
| Beta | n/a |
| RSI | 52.89 |
| Earnings Date | Apr 29, 2026 |
About Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through we... [Read more]
Financial Performance
In 2025, Teladoc Health's revenue was $2.53 billion, a decrease of -1.54% compared to the previous year's $2.57 billion. Losses were -$200.32 million, -79.99% less than in 2024.
Financial numbers in USD Financial StatementsNews
Teladoc Health Transcript: AGM 2026
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by majority vote. Stockholders participated virtually, and final results will be disclosed in a Form 8-K.
Teladoc price target raised to $7 from $6 at Citi
Citi raised the firm’s price target on Teladoc (TDOC) to $7 from $6 and keeps a Neutral rating on the shares post the Q’ report. The firm cites BetterHelp’s better…
Teladoc price target lowered to $5.50 from $6 at Stifel
Stifel lowered the firm’s price target on Teladoc (TDOC) to $5.50 from $6 and keeps a Hold rating on the shares.
Teladoc Health Earnings Call Transcript: Q1 2026
Q1 2026 revenue and Adjusted EBITDA exceeded guidance, driven by Integrated Care growth and BetterHelp's insurance rollout. Guidance for 2026 remains unchanged, with insurance revenue at BetterHelp expected to accelerate and margin expansion anticipated as insurance scales.
Teladoc Health Earnings release: Q1 2026
Teladoc Health released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Teladoc Health Slides: Q1 2026
Teladoc Health has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Teladoc Health Quarterly report: Q1 2026
Teladoc Health has published its Q1 2026 quarterly earnings report on April 29, 2026.
Teladoc Health Reports First Quarter 2026 Results
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First Qu...
Teladoc options imply 8.8% move in share price post-earnings
Pre-earnings options volume in Teladoc (TDOC) is normal with calls leading puts 19:3. Implied volatility suggests the market is anticipating a move near 8.8%, or 52c, after results are released.
Options Volatility and Implied Earnings Moves Today, April 29, 2026
Today, several major companies are expected to report earnings: Amazon (AMZN), Meta Platforms (META), Ford Motor (F), Alphabet Class A (GOOGL), Microsoft (MSFT), Qualcomm (QCOM), AbbVie (ABBV), Telado...
Teladoc call volume above normal and directionally bullish
Bullish option flow detected in Teladoc (TDOC) with 13,719 calls trading, 2x expected, and implied vol increasing almost 2 points to 77.52%. 4/24 weekly 6 calls and May-26 6 calls…
Teladoc Health to Announce First Quarter 2026 Financial Results
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026...
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you ...
Teladoc price target raised to $6 from $5 at Evercore ISI
Evercore ISI raised the firm’s price target on Teladoc (TDOC) to $6 from $5 and keeps an In Line rating on the shares. The firm made several price target adjustments…
Teladoc Health Proxy statement: Proxy filing
Teladoc Health filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Teladoc Health Proxy statement: Proxy filing
Teladoc Health filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Activist Pineal Capital pushes Teladoc to consider split, other changes to boost value
Activist investor Pineal Capital Management has urged sweeping changes at Teladoc Health , calling for cost cuts and a potential breakup of the telehealth provider to unlock shareholder value.
Pineal Capital urges Teladoc to cut more costs, consider break-up of core units
Pineal Capital Management issued an open letter to the Board of Teladoc (TDOC) Health saying it has engaged with the board and management team of Teladoc for “several months.” “Whilst…
Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc.
DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management: Board of DirectorsTeladoc Health, Inc.2 Manhattanville Road, Suite 203Purchase, NY 10577...
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immedia...
Teladoc price target lowered to $7 from $8.50 at Barclays
Barclays lowered the firm’s price target on Teladoc (TDOC) to $7 from $8.50 and keeps an Equal Weight rating on the shares after meeting with management. There is reason for…
Teladoc price target lowered to $7 from $9 at JPMorgan
JPMorgan lowered the firm’s price target on Teladoc (TDOC) to $7 from $9 and keeps a Neutral rating on the shares. The firm updated the company’s estimates post earnings. Published…
Teladoc Health Transcript: Barclays 28th Annual Global Healthcare Conference
Leadership has focused on strategic transformation, shifting to visit-based revenues and expanding insurance coverage, especially in BetterHelp. Growth is expected from chronic care, international markets, and AI-driven innovation, with financial discipline and targeted M&A supporting future performance.
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
Teladoc Health to Participate in Upcoming Investor Conference
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the B...